HLB SCIENCE Inc. Logo

HLB SCIENCE Inc.

Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.

343090 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 송파구 법원로 128씨동 1314호, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB SCIENCE Inc. is a global biopharmaceutical company dedicated to developing innovative new drugs for infectious and immune-related diseases. The company's core pipeline focuses on critical unmet medical needs, including therapeutics for bacterial sepsis and infections caused by superbacteria. A key candidate, DD-S052P, is a novel antibiotic designed to neutralize both pathogens and the endotoxins they release. In the field of neurodegenerative diseases, HLB SCIENCE is advancing a treatment for Alzheimer's Disease, DD-A279, which modulates LPS and gram-negative bacteria, complemented by the DD-A514 diagnostic kit for early detection. The company leverages its expertise in life science and medicine to contribute to global health through its innovative therapeutic and diagnostic solutions.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HLB SCIENCE Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HLB SCIENCE Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HLB SCIENCE Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Daebonglsco.,Ltd Logo
Develops raw materials and APIs for the personal care, pharmaceutical, and food industries.
South Korea 078140
DaehanPharmaceutical Logo
Develops and manufactures pharmaceuticals and health foods for human and animal markets worldwide.
South Korea 023910
Daesung Microbiological Labs. Co. Ltd Logo
Researches and manufactures veterinary vaccines and medicines for livestock, fish, and canines.
South Korea 036480
DAEWOONG PHARMA Logo
A global R&D partner for drug development, manufacturing, and commercialization services.
South Korea 069620
DAIICHI SANKYO COMPANY, LIMITED Logo
A global pharmaceutical firm developing novel therapies with a focus on oncology and ADCs.
Japan 4568
Daito Pharmaceutical Co., Ltd. Logo
Manufactures APIs, generic drugs, and health foods; provides contract manufacturing services.
Japan 4577
D&D Pharmatech Inc. Logo
Develops oral & injectable peptide therapies for metabolic & chronic diseases like obesity.
South Korea 347850
Dechra Pharmaceuticals PLC Logo
Develops & sells veterinary pharmaceuticals for companion animals, exclusively to veterinarians.
United Kingdom DPH
Dermapharm Holding SE Logo
Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.
Germany DMP
Deutsche Biotech Innovativ AG Logo
Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.
Germany DBI

Talk to a Data Expert

Have a question? We'll get back to you promptly.